Corvus Pharmaceuticals - 54 Year Dividend History | CRVS
Historical dividend payout and yield for Corvus Pharmaceuticals (CRVS) since 1971. The current TTM dividend payout for Corvus Pharmaceuticals (CRVS) as of January 17, 2025 is $0.00. The current dividend yield for Corvus Pharmaceuticals as of January 17, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.322B |
$0.000B |
|
Corvus Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of immuno-oncology therapies to harness the immune system to attack cancer cells. Its products include CPI-444, Adenosine production inhibitor, Adenosine A2B antagonist and Interleukin-2 (IL-2)-inducible T cell kinase (ITK) inhibitors. Corvus Pharmaceuticals, Inc. is based in Burlingame, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
